All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ABMD / Abiomed Inc.
|
|
|
|
|
|
|
|
| ONEM / 1life Healthcare Inc
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| LPTX / Cypherpunk Technologies Inc.
|
|
|
|
|
|
|
|
| NVAX / Novavax, Inc. Call
|
|
|
|
|
|
|
|
| KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| GNW / Genworth Financial, Inc.
|
|
|
|
|
|
|
|
| ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
| UWMC / UWM Holdings Corporation
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
| SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
| VIR / Vir Biotechnology, Inc. Put
|
|
|
|
|
|
|
|
| SGEN / Seagen Inc
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| DRRX / DURECT Corporation
|
|
|
|
|
|
|
|
| BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
| ATHX / Athersys, Inc.
|
|
|
|
|
|
|
|
| CCXI / Churchill Capital Corp XI
|
|
|
|
|
|
|
|
| CASA / Casa Systems, Inc.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| AVAH / Aveanna Healthcare Holdings Inc.
|
|
|
|
|
|
|
|
| CANO / Cano Health, Inc.
|
|
|
|
|
|
|
|
| TCDA / Tricida Inc
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SKLZ / Skillz Inc.
|
|
|
|
|
|
|
|
| NLY / Annaly Capital Management, Inc.
|
|
|
|
|
|
|
|
| AMWL / American Well Corporation
|
|
|
|
|
|
|
|
| INSG / Inseego Corp.
|
|
|
|
|
|
|
|
| EW / Edwards Lifesciences Corporation
|
|
|
|
|
|
|
|
| SPNT / SiriusPoint Ltd.
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| EVH / Evolent Health, Inc.
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SKIN / SkinHealth Systems Inc.
|
|
|
|
|
|
|
|
| SKIN / SkinHealth Systems Inc. Call
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BNTX / BioNTech SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CTLT / Catalent, Inc.
|
|
|
|
|
|
|
|
| INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
| REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
| LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| FEMY / Femasys Inc.
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| STVN / Stevanato Group S.p.A.
|
|
|
|
|
|
|
|
| ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
